These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 11398808)
1. Granulysin blocks replication of varicella-zoster virus and triggers apoptosis of infected cells. Hata A; Zerboni L; Sommer M; Kaspar AA; Clayberger C; Krensky AM; Arvin AM Viral Immunol; 2001; 14(2):125-33. PubMed ID: 11398808 [TBL] [Abstract][Full Text] [Related]
2. Antimicrobial Properties of an Immunomodulator - 15 kDa Human Granulysin. Wei HM; Lin LC; Wang CF; Lee YJ; Chen YT; Liao YD PLoS One; 2016; 11(6):e0156321. PubMed ID: 27276051 [TBL] [Abstract][Full Text] [Related]
3. [Granulysin: antimicrobial molecule of innate and acquired immunity in human tuberculosis]. Wargnier A; Sasportes M; Lagrange PH Pathol Biol (Paris); 2005; 53(8-9):516-21. PubMed ID: 16081226 [TBL] [Abstract][Full Text] [Related]
4. Granulysin: a novel antimicrobial peptide of cytolytic T lymphocytes and natural killer cells. Krensky AM Biochem Pharmacol; 2000 Feb; 59(4):317-20. PubMed ID: 10644038 [TBL] [Abstract][Full Text] [Related]
5. Hemolysis of erythrocytes by granulysin-derived peptides but not by granulysin. Li Q; Dong C; Deng A; Katsumata M; Nakadai A; Kawada T; Okada S; Clayberger C; Krensky AM Antimicrob Agents Chemother; 2005 Jan; 49(1):388-97. PubMed ID: 15616319 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of acetylsalicylic acid on replication of varicella-zoster virus. Primache V; Binda S; De Benedittis G; Barbi M New Microbiol; 1998 Oct; 21(4):397-401. PubMed ID: 9812322 [TBL] [Abstract][Full Text] [Related]
8. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2. Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro. Sasivimolphan P; Lipipun V; Likhitwitayawuid K; Takemoto M; Pramyothin P; Hattori M; Shiraki K Antiviral Res; 2009 Oct; 84(1):95-7. PubMed ID: 19635502 [TBL] [Abstract][Full Text] [Related]
10. Granulysin induces cell death with nuclear accumulation. Takamori Y; Ogawa K; Nagata K; Takano S; Nakamura M J Med Dent Sci; 2005 Mar; 52(1):1-7. PubMed ID: 15868735 [TBL] [Abstract][Full Text] [Related]
11. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype. Arvin AM; Sharp M; Smith S; Koropchak CM; Diaz PS; Kinchington P; Ruyechan W; Hay J J Immunol; 1991 Jan; 146(1):257-64. PubMed ID: 1670603 [TBL] [Abstract][Full Text] [Related]
12. Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin. Wang Z; Choice E; Kaspar A; Hanson D; Okada S; Lyu SC; Krensky AM; Clayberger C J Immunol; 2000 Aug; 165(3):1486-90. PubMed ID: 10903754 [TBL] [Abstract][Full Text] [Related]
13. Human ocular-derived virus-specific CD4+ T cells control varicella zoster virus replication in human retinal pigment epithelial cells. Milikan JC; Baarsma GS; Kuijpers RW; Osterhaus AD; Verjans GM Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):743-51. PubMed ID: 18936136 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil. Yokota T; Konno K; Mori S; Shigeta S; Kumagai M; Watanabe Y; Machida H Mol Pharmacol; 1989 Aug; 36(2):312-6. PubMed ID: 2549386 [TBL] [Abstract][Full Text] [Related]